TLSA
Tiziana Life Sciences Ltd.
NASDAQ · Healthcare · Biotechnology · GB
$1.01
−3.81%Next report
Analyst consensus
- Next report date
- Mar 3, 2027
- EPS estimate
- -$0.08
- Revenue estimate
- —
Latest reported
- Last report date
- Oct 16, 2026
- EPS actual
- -$0.08
- EPS estimate
- -$0.08
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 1
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -89.2%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Oct 16, 2026 | -$0.08 | -$0.08 | Miss -2.18% | — |
| Sep 18, 2026 | -$0.08 | -$0.08 | Miss -1.31% | — |
| May 1, 2026 | -$0.11 | -$0.22 | Miss -100.31% | — |
| Jan 8, 2024 | — | -$0.22 | — | — |
| Jul 26, 2023 | — | -$0.21 | — | — |
| Aug 19, 2022 | — | -$0.11 | — | — |
| Sep 24, 2021 | -$0.06 | -$0.20 | Miss -253.17% | — |
| May 17, 2021 | -$0.05 | -$0.08 | Miss -46.89% | — |
| Sep 30, 2020 | -$0.01 | -$0.06 | Miss -536.80% | — |
| Jun 17, 2020 | -$0.02 | -$0.03 | Miss -20.32% | — |
| Sep 30, 2019 | -$0.04 | -$0.01 | Beat 63.42% | — |
| Jun 30, 2018 | — | -$0.06 | — | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 3, 2027